Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Epirubicin: Observational Study
Sponsor: Pfizer